Search

Author/Creator Ansaldi, Christelle

1. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition. (July 2020)

Authors:
Bestion, Eloïne; Jilkova, Zuzana Macek; Mège, Jean-Louis; Novello, Marie; Kurma, Keerthi; Pour, Seyedeh Tayebeh Ahmad; Lalmanach, Gilles; Vanderlynden, Lise; Fizanne, Lionel; Bassissi, Firas; Rachid, Madani; Tracz, Jennifer; Boursier, Jérôme; Courcambeck, Jérôme; Serdjebi, Cindy; Ansaldi, Christe...
Journal:
Therapeutic advances in chronic disease
Issue:
Volume 11(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions. Issue 3 (4th March 2022)

Authors:
Brun, Sonia; Bestion, Eloïne; Raymond, Eric; Bassissi, Firas; Jilkova, Zuzana Macek; Mezouar, Soraya; Rachid, Madani; Novello, Marie; Tracz, Jennifer; Hamaï, Ahmed; Lalmanach, Gilles; Vanderlynden, Lise; Legouffe, Raphael; Stauber, Jonathan; Schubert, Thomas; Plach, Maximilian G.; Courcambeck, Jé...
Journal:
Autophagy
Issue:
Volume 18:Issue 3(2022)
Page Start:
678
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗